![logo](/logos/HROW.webp)
Harrow Health, Inc.
NASDAQ:HROW
37.98 (USD) • At close September 6, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Harrow Health, Inc. |
Symbool | HROW |
Munteenheid | USD |
Prijs | 37.98 |
Beurswaarde | 1,347,640,542 |
Dividendpercentage | 0% |
52-weken bereik | 7.6 - 44.8 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Mark L. Baum J.D. |
Website | https://www.harrowinc.com |
An error occurred while fetching data.
Over Harrow Health, Inc.
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)